Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Carcinoma, Basal Cell × methyl 5-aminolevulinate × Clear all

Phase

Phase 3 3 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 2 Skin Diseases 1 Connective Tissue Diseases 1 Carcinoma, Basal Cell 1 Bowen's Disease 1

Interventions

Imiquimod 4 HhAntag691 2 methyl 5-aminolevulinate 1 Therapeutics 1 Interferon-alpha 1 Immunologic Factors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01491711 2014-01-31

Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate

Maastricht University Medical Center

Phase 4 Unknown

Carcinoma, Basal Cell, Connective Tissue Diseases, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡